- Market Realist•53 minutes ago
On September 20, 2016, Regeneron Pharmaceuticals (REGN) entered a collaboration agreement with Teva Pharmaceuticals (TEVA).
- Investor's Business Daily•2 hours ago
Amgen will likely beat Eli Lilly, Alder and Teva to market with an antibody-blocking migraine med.
- Market Realist•4 hours ago
Teva Pharmaceutical’s (TEVA) strategy of selectively focusing on certain countries has enabled it to see double-digit organic growth in the growth markets.
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||46.43 x 600|
|Ask||46.44 x 200|
|Day's Range||46.08 - 48.88|
|52wk Range||46.08 - 66.55|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||30.92|
|Avg Vol (3m)||5,825,100|
|Dividend & Yield||1.36 (2.75%)|